BCSI Announces Efforts to Use pH Monitoring to Identify Compromised Platelet Products

DENVER, Oct. 14, 2013 /PRNewswire/ -- Blood Cell Storage, Inc. (BCSI), a leading medical device provider based in Seattle, WA announced today during the annual AABB meeting in Denver, Colorado, that they are exploring the viability of using the pH SAFE^® products with regular pH readings to identify compromised platelet products.  Laboratory studies are underway whereby multiple daily pH measurements are being collected and where significant changes are being assessed in correlation with bacterial contamination.

This research is important in the effort to help identify and remove bacterially contaminated platelet units from inventory. Older platelets can also be pH monitored to ensure their acceptable performance.

"Since visual signs of contamination are difficult to detect," said Russ Aldrich, CEO, BCSI. "We believe that using pH measurements to alert for possible bacterial contamination may be an additional way to identify compromised platelet products."

About BCSI

Blood Cell Storage, Inc. (BCSI) www.bloodcellstorage.com is a privately held international medical device company based in Seattle, Washington, with European operations located in The Netherlands.

BCSI has created two unique product lines that benefit patients, clinicians, researchers, pathologists and doctors using patented technologies. Our fluorescent dyes, micro-fluidics, Nucleic Acid Extraction capabilities and automated systems reduce healthcare costs while improving patient outcomes. www.safesens.com

pH SAFE is a registered trademark of BCSI. All other names or product names mentioned in this release are trademarks or registered trademarks of their respective companies.

CONTACT:
Steve Geelhood
SAFE Systems Product Manager
BCSI
[email protected]
+1-206-812-1521 x521

SOURCE Blood Cell Storage, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED